Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.14 -0.04 (-3.39%)
As of: Sep 29, 2026 · 3:59 PM EDT

Actinium Pharmaceuticals (ATNM) FCF Margin (2021 - 2026)

Updated

Actinium Pharmaceuticals (ATNM) recorded FCF Margin of -16.16% in Q2 2026.

Analysis

Actinium Pharmaceuticals (ATNM) FCF Margin (2021 - 2026) Analysis & Trends

On a TTM basis, Actinium Pharmaceuticals' FCF Margin came in at -65.95% as of Jun 30, 2026; for FY2025, it was -27426.67%.

  • Annual FCF Margin has a four-year change of -25591.09 percentage points (FY2021 to FY2025).
  • Across earlier years, FCF Margin came in at -58627.16% in FY2023 (-59430.85 pp), 803.69% in FY2022 (+2639.27 pp) and -1835.58% in FY2021.
  • The Q2 2026 figure is the highest quarterly FCF Margin since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Actinium Pharmaceuticals 37.10 Mn 37.10 Mn - -16.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.16%
Sep 30, 2025 -7,027.78%
Sep 30, 2022 -12,862.22%
Jun 30, 2022 61,440.00%
Mar 31, 2022 -615.74%
Dec 31, 2021 -21,965.22%
Sep 30, 2021 -2,427.47%
Jun 30, 2021 -1,746.24%
Mar 31, 2021 -907.72%
API Access

Actinium Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ATNM&period=max&api_key=YOUR_API_KEY